Limulus Amebocyte Lysate (LAL) Kinetic Chromogenic Reagent for Bacterial Endotoxin Testing

Hero Section

Pharmaceutical-Grade LAL Reagent — Validated Sensitivity, Lot-to-Lot Consistency, Full Compendial Compliance LAL reagent

This kinetic chromogenic LAL reagent delivers reproducible endotoxin quantification across production lots, with documented sensitivity thresholds suitable for parenteral drug release testing. Manufactured under FDA license with full traceability, it is formulated to meet the stringent inter-assay precision requirements of GMP-regulated quality control laboratories.

Technical Specifications & Compliance

Regulatory Alignment

• USP <85> — Bacterial Endotoxins Test, compendial procedure compliance
• USP <86> — Bacterial Endotoxins Test Procedures (kinetic/photometric methods)
• EP 2.6.14 — Bacterial Endotoxins, European Pharmacopoeia
• JP 4.01 — Bacterial Endotoxins Test, Japanese Pharmacopoeia
• Manufactured under FDA license with full Certificate of Analysis (CoA) traceability per lot

Sensitivity Range

• Labeled sensitivity (λ): 0.005 EU/mL to 5.0 EU/mL, lot-specific and verified against the USP Endotoxin Reference Standard (RSE) or Control Standard Endotoxin (CSE)
• Standard curve range validated across 4-log dynamic range for kinetic chromogenic quantification
• Maximum Valid Dilution (MVD) and endotoxin limit calculations supported per product-specific worksheet

Methodology

• Kinetic Chromogenic (primary format): continuous absorbance monitoring at 405 nm, onset-time quantification against log-log standard curve
• End-Point Chromogenic variant available for single-timepoint absorbance measurement
• Gel-Clot format available for qualitative/semi-quantitative limit testing where photometric instrumentation is unavailable

Core Applications

Injectable Drug Formulation & Vaccine Quality Control Applied to final drug product release testing for parenterals, biologics, and vaccine formulations, supporting endotoxin limit specifications defined by dose and route of administration.

Medical Device Rinsing & Surface Sterility Verification Used in device-eluate testing following USP <161> extraction protocols to confirm endotoxin levels on implantable and invasive device surfaces meet FDA-cleared limits.

Raw Material & Water-for-Injection (WFI) Screening Deployed for incoming raw material qualification, in-process bioburden monitoring, and routine WFI system validation to detect endotoxin contamination upstream of formulation.

Industry Transition: Natural-Derived LAL and the Path Toward Recombinant Methods

Laboratories continue to rely on natural-source LAL reagents due to their decades of regulatory precedent and continuity with historical validation data — a critical factor for sites maintaining long-term product stability and comparability studies. This reagent is manufactured under rigorous FDA-licensed production controls, with each lot subjected to sensitivity confirmation and inhibition/enhancement testing to ensure consistency with prior release data.

For laboratories transitioning toward Recombinant Factor C (rFC) assays, this manufacturer also supports parallel qualification studies, providing method-bridging documentation to facilitate equivalency assessments between LAL and rFC platforms without disrupting existing compendial compliance pathways. Sites evaluating animal-free alternatives can request comparative data packages to support internal change-control and regulatory submission requirements.

Documentation & Procurement

Access the full technical package prior to purchase order submission:

• Safety Data Sheet (SDS)
• Certificate of Analysis (CoA) — lot-specific sensitivity and inhibition/enhancement data
• Validation Guide — includes standard curve protocols, MVD calculation worksheets, and inhibition/enhancement study templates

[Download Technical Documentation →]

Procurement managers and laboratory directors may request a sample batch for incoming qualification or schedule a consultation with an applications specialist to align reagent selection with existing assay validation protocols and regulatory submission timelines.

[Request Sample Batch]   |   [Schedule Technical Consultation]